Global COVID Lab Meeting

ACE2, the SARS-CoV-2 S protein, and better RBD-based vaccines

Aug 27, 2020

Michael Farzan

The Scripps Research Institute

About Michael Farzan

Dr. Farzan’s laboratory focuses on the entry processes of enveloped viruses and the various ways that the innate and adaptive immune responses inhibit these processes. His team applies these insights toward developing therapeutic strategies that enhance or supplement these immune responses. In this Global COVID Lab Meeting, Dr. Farzan will share his findings on efforts to develop a safe and effective vaccine that triggers antibodies against the novel coronavirus.